NasdaqCM - Delayed Quote USD

P3 Health Partners Inc. (PIII)

0.5400 -0.0500 (-8.47%)
At close: May 28 at 4:00 PM EDT
0.5103 -0.03 (-5.50%)
After hours: May 28 at 6:47 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2020
12/31/2019
Total Revenue
1,352,786.0000
1,266,375.0000
1,049,471.0000
491,063.5250
145,482.1120
Operating Expense
1,515,730.0000
1,434,305.0000
1,295,432.0000
519,651.2030
185,017.7830
Operating Income
-162,944.0000
-167,930.0000
-245,961.0000
-28,587.6780
-39,535.6710
Net Non Operating Interest Income Expense
-16,155.0000
-15,985.0000
-11,404.0000
-2,533.1800
-2,533.8420
Other Income Expense
-8.0000
184.0000
-1,302,330.0000
-290.6840
97.9550
Pretax Income
-179,107.0000
-183,731.0000
-1,559,695.0000
-31,411.5420
-41,971.5580
Tax Provision
4,477.0000
2,695.0000
1,862.0000
--
--
Net Income Common Stockholders
-67,274.0000
-57,773.0000
-270,127.0000
-31,411.5420
-41,971.5580
Diluted NI Available to Com Stockholders
-67,274.0000
-57,773.0000
-270,127.0000
-31,411.5420
-41,971.5580
Basic EPS
-0.55
--
-6.50
-0.46
-0.62
Diluted EPS
-0.57
--
-6.50
-0.46
-0.62
Basic Average Shares
114,216.0000
--
41,579.0000
68,159.5320
68,159.5320
Diluted Average Shares
313,917.0000
--
41,579.0000
68,159.5320
68,159.5320
Total Operating Income as Reported
-162,944.0000
-167,930.0000
-1,560,913.0000
-28,587.6780
-39,535.6710
Total Expenses
1,515,730.0000
1,434,305.0000
1,295,432.0000
519,651.2030
185,017.7830
Net Income from Continuing & Discontinued Operation
-67,274.0000
-57,773.0000
-270,127.0000
-31,411.5420
-41,971.5580
Normalized Income
-67,274.0000
-58,115.0700
760,891.7300
-31,411.5420
-41,971.5580
Interest Expense
16,155.0000
15,985.0000
11,404.0000
2,533.1800
2,533.8420
Net Interest Income
-16,155.0000
-15,985.0000
-11,404.0000
-2,533.1800
-2,533.8420
EBIT
-162,952.0000
-167,746.0000
-1,548,291.0000
-28,878.3620
-39,437.7160
EBITDA
-76,278.0000
-81,071.0000
-1,461,002.0000
-28,083.1900
-39,038.5390
Reconciled Depreciation
86,674.0000
86,675.0000
87,289.0000
795.1720
399.1770
Net Income from Continuing Operation Net Minority Interest
-67,274.0000
-57,773.0000
-270,127.0000
-31,411.5420
-41,971.5580
Total Unusual Items Excluding Goodwill
--
433.0000
-1,305,087.0000
--
--
Total Unusual Items
--
433.0000
-1,305,087.0000
--
--
Normalized EBITDA
-76,278.0000
-81,504.0000
-155,915.0000
-28,083.1900
-39,038.5390
Tax Rate for Calcs
0.0004
0.0002
0.0002
--
--
Tax Effect of Unusual Items
--
90.9300
-274,068.2700
--
--
12/31/2019 - 4/6/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AONC American Oncology Network, Inc.
2.3600
+10.80%
 
CCM Concord Medical Services Holdings Limited
0.6557
-2.02%
 
SYRA Syra Health Corp.
1.4300
+2.14%
 
ASTH Astrana Health, Inc.
39.96
-0.03%
 
IONM Assure Holdings Corp.
0.4473
+3.95%
 
NVOS Novo Integrated Sciences, Inc.
0.4753
-5.41%
 
BACK IMAC Holdings, Inc.
3.2100
-3.60%
 
TOI The Oncology Institute, Inc.
0.4790
-8.76%
 
NIVF NewGenIvf Group Limited
1.1500
+8.49%
 
AIRS AirSculpt Technologies, Inc.
4.3500
+23.93%